Bowman Meredyth, Sclamberg Gracie, Wessels Emma, Cragg Kyle, Donneys Alexis, Hankenson Kurt D, Hake Mark E, Alford Andrea I
Department of Orthopedic Surgery, University of Michigan School of Medicine, A. Alfred Taubman Biomedical Sciences Research Building, Ann Arbor, Michigan, USA.
Trinity IHA Medical Group, Orthopedics-Ann Arbor Campus Yspilanti, Yspilant, Michigan, USA.
J Orthop Res. 2025 May;43(5):922-930. doi: 10.1002/jor.26053. Epub 2025 Feb 8.
Masquelet's induced membrane technique (MIMT) is a staged surgical procedure that leverages the foreign body induced membrane (IM) that forms around a cement spacer placed into a segmental bone defect to support subsequent bone grafting. The mechanisms by which the IM supports bone consolidation are not fully understood. We present an indirect coculture system for studying IM-MSC interactions using a rat model of MIMT. Compared to control cells, MSC Tnap (alkaline phosphatase) was induced by 4- but not 8-week IM. MSC Spp1 (Osteopontin) was attenuated by both 4- and 8-week IM. Although Tnfrsf11b (osteoprotegrin) in MSC exposed to IM was not different from control cells, it was induced by 8-week IM compared to 4-week IM. MSC Tnfsf11 (RANKL) was reduced by 4-week and 8-week IM. MSC Thbs2 (Tsp2) was induced by 8-week but not 4-week IM. Ablation of macrophages in IM blocked the induction of Thbs2 by 8-week IM. MSC Col1a1 expression was not affected under any condition tested. TMT proteomics analysis of IM-conditioned medium revealed 150 unique secreted proteins, 7 of which were differentially abundant (fold change ≥ 2 and FDR corrected p ≤ 0.05) in 8-week versus 4-week IM secretomes. All differentially abundant proteins were elevated in medium conditioned by 8-week IM. Our data suggest that factor(s) secreted by IM resident cells affect MSC gene expression, and that duration of IM development influences the potency and nature of this paracrine effect. Patient-specific factors including age and interval between MIMT surgeries may affect IM biological potency and graft to bone consolidation.
马斯克莱诱导膜技术(MIMT)是一种分阶段的外科手术,它利用在置于节段性骨缺损处的骨水泥间隔物周围形成的异物诱导膜(IM)来支持后续的骨移植。IM支持骨愈合的机制尚未完全了解。我们使用MIMT大鼠模型提出了一种间接共培养系统,用于研究IM与间充质干细胞(MSC)的相互作用。与对照细胞相比,4周而非8周的IM可诱导MSC的Tnap(碱性磷酸酶)。4周和8周的IM均使MSC的Spp1(骨桥蛋白)表达减弱。尽管暴露于IM的MSC中的Tnfrsf11b(骨保护素)与对照细胞无差异,但与4周的IM相比,8周的IM可诱导其表达。4周和8周的IM均可使MSC的Tnfsf11(核因子κB受体活化因子配体,RANKL)表达降低。8周而非4周的IM可诱导MSC的Thbs2(血小板反应蛋白2,Tsp2)表达。去除IM中的巨噬细胞可阻断8周IM对Thbs2的诱导。在任何测试条件下,MSC的Col1a1表达均未受影响。对IM条件培养基的串联质谱标签(TMT)蛋白质组学分析显示有150种独特的分泌蛋白,其中7种在8周与4周IM分泌组中的丰度差异显著(倍数变化≥2且错误发现率校正P≤0.05)。所有差异丰度蛋白在8周IM条件培养基中均升高。我们的数据表明,IM驻留细胞分泌的因子会影响MSC基因表达,且IM形成的持续时间会影响这种旁分泌作用的效力和性质。包括年龄和MIMT手术间隔时间在内的患者特异性因素可能会影响IM的生物学效力以及移植物与骨愈合。